81 FR 19213 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 64 (April 4, 2016)

Page Range		19213-19213
FR Document		2016-07497

Federal Register, Volume 81 Issue 64 (Monday, April 4, 2016)

[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19213]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-07497]



[[Page 19213]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Child Neurology K12 Review.
    Date: April 15, 2016.
    Time: 3:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: William C. Benzing, Ph.D., Scientific Review 
Administrator, Scientific Review Branch, NINDS/NIH/DHHS, 
Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, 
Bethesda, MD 20892-9529, 301-496-0660, [email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; P01 Review.
    Date: April 29, 2016.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Natalia Strunnikova, Ph.D., Scientific Review 
Administrator, Scientific Review Branch, NINDS/NIH/DHHS, 
Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529, 
Bethesda, MD 20892-9529, 301-402-0288, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: March 24, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-07497 Filed 4-1-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices 19213

DEPARTMENT OF HEALTH AND Dated: March 24, 2016. of America. The prospective start-up
HUMAN SERVICES Sylvia L. Neal, exclusive license territory may be
Program Analyst, Office of Federal Advisory worldwide and the field of use may be
National Institutes of Health Committee Policy. limited to therapeutics for Multiple
[FR Doc. 2016–07497 Filed 4–1–16; 8:45 am] sclerosis, Acute Disseminated
National Institute of Neurological BILLING CODE 4140–01–P Encephalomyelitis (ADEM), Balo’s
Disorders and Stroke; Notice of Closed disease, Clinically Isolated Syndrome,
Meetings HTLV–1 Associated Myelopathy (HAM),
DEPARTMENT OF HEALTH AND Neuromyelitis optica and NMO
Pursuant to section 10(d) of the HUMAN SERVICES spectrum disorder, Schilder’s disease,
Federal Advisory Committee Act, as Traverse myelitis, amyotrophic lateral
amended (5 U.S.C. App.), notice is National Institutes of Health sclerosis and other motor neuron
hereby given of the following meetings. diseases as follows: progressive bulbar
Center for Scientific Review; Amended palsy, primary lateral sclerosis,
The meetings will be closed to the
Notice of Meeting progressive muscular atrophy, spinal
public in accordance with the
provisions set forth in sections Notice is hereby given of a change in muscular atrophy, Kennedy’s disease,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., the meeting of the Center for Scientific and post polio syndrome.
as amended. The grant applications and Review Special Emphasis Panel, April DATES: Only written comments and/or
the discussions could disclose 13, 2016, 01:00 p.m. to April 13, 2016, applications for a license which are
confidential trade secrets or commercial 04:00 p.m., National Institutes of Health, received by NINDS Technology Transfer
property such as patentable material, 6701 Rockledge Drive, Bethesda, MD on or before April 19, 2016 will be
and personal information concerning 20892 which was published in the considered.
individuals associated with the grant Federal Register on March 23, 2016, 81 ADDRESSES: Requests for copies of the
applications, the disclosure of which FR 15543. patent application, inquiries, comments,
would constitute a clearly unwarranted The meeting will be held on April 7, and other materials relating to the
invasion of personal privacy. 2016 at 12:00 p.m.–4:00 p.m. The Panel contemplated start-up exclusive license
Name of Committee: National Institute of
Name of the meeting will be should be directed to: Susan Ano, Ph.D.,
Neurological Disorders and Stroke Special
‘‘Neurophysiology’’. The location NINDS Technology Transfer, 31 Center
Emphasis Panel; Child Neurology K12 remains the same. The meeting is closed Drive, Suite 8A52, MS2540, Bethesda,
Review. to the public. MD 20892; Telephone: (301) 435–5515;
Date: April 15, 2016. Dated: March 25, 2016. Email: anos@mail.nih.gov.
Time: 3:00 p.m. to 5:00 p.m. Carolyn Baum, SUPPLEMENTARY INFORMATION: This
Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory invention discloses treating
applications. Committee Policy. neurodegenerative diseases by
Place: National Institutes of Health, [FR Doc. 2016–07480 Filed 4–1–16; 8:45 am] administering cyclin dependent kinase
Neuroscience Center, 6001 Executive 5 (Cdk5) inhibitory peptides derived
BILLING CODE 4140–01–P
Boulevard, Rockville, MD 20852, (Telephone from P35, the activator of Cdk5.
Conference Call). Abnormally hyperactive Cdk5 has been
Contact Person: William C. Benzing, Ph.D., DEPARTMENT OF HEALTH AND shown to be associated with a variety of
Scientific Review Administrator, Scientific neurodegenerative disorders. This
HUMAN SERVICES
Review Branch, NINDS/NIH/DHHS, invention describes isolated peptide
Neuroscience Center, 6001 Executive Blvd., National Institutes of Health fragments, pharmaceutical compositions
Suite 3204, MSC 9529, Bethesda, MD 20892–
and methods for use of such for treating
9529, 301–496–0660, lbenzingw@ Prospective Grant of Start-Up subjects with a neurodegenerative
mail.nih.gov. Exclusive License: Therapeutics for disease, such as Alzheimer’s disease
Name of Committee: National Institute of Multiple Sclerosis, Amyotrophic (AD), Amyotrophic Lateral Sclerosis
Neurological Disorders and Stroke Special Lateral Sclerosis and Certain Other (ALS) and Parkinson’s disease (PD). An
Emphasis Panel; P01 Review. CNS Disorders inhibitory fragment, TFP5, disclosed in
Date: April 29, 2016.
AGENCY: National Institutes of Health, this invention, has been shown to
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant HHS. ameliorate symptoms of AD in disease
applications. ACTION: Notice. animal models without any evidence of
Place: National Institutes of Health, toxicity. In particular, TFP5 treatment of
Neuroscience Center, 6001 Executive SUMMARY: This is notice, in accordance rat cortical neurons reduced
Boulevard, Rockville, MD 20852, (Telephone with 35 U.S.C. 209 and 37 CFR part 404, hyperactivation of Cdk5 upon neuronal
Conference Call). that the National Institute of stress and insults. Following
Contact Person: Natalia Strunnikova, Neurological Disorders and Stroke intraperitoneal (ip) injection, TFP5 was
Ph.D., Scientific Review Administrator, (NINDS), National Institutes of Health capable of crossing the blood-brain
Scientific Review Branch, NINDS/NIH/ (NIH), Department of Health and Human barrier and localizing within the brain
DHHS, Neuroscience Center, 6001 Executive Services, is contemplating the grant of a where it was found to rescue memory
Blvd., Suite 3204, MSC 9529, Bethesda, MD start-up exclusive license to Great Lakes deficits and pathology in a double
mstockstill on DSK4VPTVN1PROD with NOTICES

20892–9529, 301–402–0288, Neuroscience, Inc., which is located in transgenic mouse (APP/PS1) AD model.
Natalia.strunnikova@nih.gov. Illinois, to practice the inventions The prospective start-up exclusive
(Catalogue of Federal Domestic Assistance embodied in the following patents: U.S. license may be granted unless within
Program Nos. 93.853, Clinical Research Patent 8,597,660, issued December 3, fifteen (15) days from the date of this
Related to Neurological Disorders; 93.854, 2013 (HHS reference E–144–2010/0– published notice, the NIH receives
Biological Basis Research in the US–02). written evidence and argument that
Neurosciences, National Institutes of Health, The patent rights in these inventions establishes that the grant of the license
HHS) have been assigned to the United States would not be consistent with the

VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 PO 00000 Frm 00102 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1

Document Created: 2016-04-02 03:54:21
Document Modified: 2016-04-02 03:54:21

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		April 15, 2016.
FR Citation		81 FR 19213

81 FR 19213 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 64 (April 4, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health